WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

CHEMICAL-QUANTUM EVALUATION OF GLIBENCLAMIDE INTERACTIONS VS. SARS-COV-2

José Carlos Zúñiga-Ramírez, Nancy Zamora-Puga, Dulce Rocío Pérez-Juárez, *Manuel González-Pérez

ABSTRACT

The present investigation addresses the chemical-quantum interaction of Glibenclamide (Gbn) and the evaluation of the relationship with the Amino Acids (AAs) of SARS-CoV-2. HyperChem is a sophisticated molecular modeling environment known for its quality, flexibility, and ease of use. The Semi-Empirical Parametric Method 3 (SE-PM3) is used in hyperchem as the basis for all calculations. This method treats the molecule as a collection of valence electrons and atomic centers; each center consists of an atom and its inner electrons. Results: The strongest and most probable interactions take place at the bottom of the quantum well (first quartile of 441 probable interactions). These interactions are 16 antioxidants and 21 oxidants. Total = 47 interactions. Medications like Remdesivir only contain 22 strongest and most likely interactions. We concluded Gbn is a drug that can save covid-19 patients, and it can be verified with the hypothesis: "diabetic patients who take Gbn are less likely to suffer from covid-19 disease than patients do not ingest Gbn".

Keywords: Glibenclamide, Diabetes Type 2, Sars-cov-2, Covid-19, Insulin.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More